A mild phenoxysilyl linker for self-immolative release of antibody-drug conjugates

被引:4
|
作者
Wei, Ding [1 ,2 ,3 ]
Mao, Yurong [2 ,3 ]
Wang, Huihui [2 ,3 ]
Qu, Siqi [2 ,3 ]
Chen, Jiakang [2 ]
Li, Jiusheng [1 ]
Jiang, Biao [2 ]
Chen, Hongli [2 ]
机构
[1] Chinese Acad Sci, Shanghai Adv Res Inst, Shanghai 201210, Peoples R China
[2] ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Shanghai 201210, Peoples R China
[3] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
关键词
Antibody-drug conjugates; Self-immolative release; Phenoxysilyl linker; Combretastatin A4 (CA4); DELIVERY; ACTIVATION; PAYLOADS; DESIGN;
D O I
10.1016/j.cclet.2022.108091
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Self-immolative linkers have been widely used to construct prodrugs to improve their efficacy and safety. In this study, we report the use of phenoxysilyl linker as a self-immolative unit to prepare antibody-drug conjugates (ADCs). Phenoxysily based ADC Ate-PPS-CA4 was prepared and its release was systematically investigated by mass spectrometry. Biological evaluation showed that Ate-PPS-CA4 displayed the ability to target delivery and self-immolative release the active payload CA4 on PD-L1 positive cells MDA-MB-231. As the same with its payload CA4, it could arrest the cell cycle to the G2/M phase and induced changes in cell morphology at the dose of its IC50. The development of this linker with novel drug release mechanisms will expand the methodology to construct ADCs, especially for non-internalizing ADCs by extracellular cleavage.(c) 2023 Published by Elsevier B.V. on behalf of Chinese Chemical Society and Institute of Materia Medica, Chinese Academy of Medical Sciences.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Chemically Cleavable Antibody-Drug Conjugates: Drug Release in One Click
    de Geus, M. A. R.
    ten Hoeve, W.
    Hudson, P.
    Janssen, H. M.
    Khasanov, A.
    van Onzen, A. H. A. M.
    Robillard, M. S.
    Rossin, R.
    Steenbergen, E. J.
    Versteegen, R. M.
    Wessels, H. J.
    Wu, J.
    SYNLETT, 2018, 29 (18) : A180 - A184
  • [42] PEGylation of Dipeptide Linker Improves Therapeutic Index and Pharmacokinetics of Antibody-Drug Conjugates
    Long, Jing
    Shao, Ting
    Wang, Yongmei
    Chen, Tianzhi
    Chen, Yuning
    Chen, Yi-Li
    Wang, Qi
    Yu, Xiong
    Yu, Jinghua
    He, Kaifeng
    Lin, Han-bin
    Diao, Xingxing
    Wang, Guifeng
    Wang, Chunhe
    BIOCONJUGATE CHEMISTRY, 2025, 36 (02) : 179 - 189
  • [43] On the use of DNA as a linker in antibody-drug conjugates: synthesis, stability and in vitro potency
    Igor Dovgan
    Anthony Ehkirch
    Victor Lehot
    Isabelle Kuhn
    Oleksandr Koniev
    Sergii Kolodych
    Alexandre Hentz
    Manon Ripoll
    Sylvain Ursuegui
    Marc Nothisen
    Sarah Cianférani
    Alain Wagner
    Scientific Reports, 10
  • [44] Antibody-Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer
    Weng, Weining
    Meng, Tao
    Zhao, Qianqian
    Shen, Yi
    Fu, Guoxiang
    Shi, Jing
    Zhang, Yue
    Wang, Zhaohui
    Wang, Mingqiao
    Pan, Rong
    Ma, Linjie
    Chen, Caiwei
    Wang, Lijun
    Zhou, Biao
    Zhang, Hui
    Pu, Junyi
    Zhang, Jianjian
    Hu, Yi Peter
    Hua, Guoqiang
    Qian, Yu
    Liu, Shu-Hui
    Hu, Wenhao
    Meng, Xun
    CANCER DISCOVERY, 2023, 13 (04) : 950 - 973
  • [45] On the use of DNA as a linker in antibody-drug conjugates: synthesis, stability and in vitro potency
    Dovgan, Igor
    Ehkirch, Anthony
    Lehot, Victor
    Kuhn, Isabelle
    Koniev, Oleksandr
    Kolodych, Sergii
    Hentz, Alexandre
    Ripoll, Manon
    Ursuegui, Sylvain
    Nothisen, Marc
    Cianferani, Sarah
    Wagner, Alain
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [46] A novel linker to enable alcohol containing payloads for the preparation of antibody-drug conjugates
    Kolakowski, Robert V.
    Haelsig, Karl
    Jeffrey, Scott
    Senter, Peter
    CANCER RESEARCH, 2016, 76
  • [47] Improving the therapeutic window of antibody-drug conjugates through novel linker design
    Meyer, D. L.
    Doronina, S. O.
    Bovee, T. D.
    Miyamoto, J. B.
    Anderson, M. E.
    Stone, I. J.
    Morris-Tilden, C. A.
    Gerber, H. P.
    Senter, P. D.
    EJC SUPPLEMENTS, 2008, 6 (12): : 167 - 167
  • [48] An Enzymatically Cleavable Tripeptide Linker for Maximizing the Therapeutic Index of Antibody-Drug Conjugates
    Ha, Summer Y. Y.
    Anami, Yasuaki
    Yamazaki, Chisato M.
    Xiong, Wei
    Haase, Candice M.
    Olson, Scott D.
    Lee, Jangsoon
    Ueno, Naoto T.
    Zhang, Ningyan
    An, Zhiqiang
    Tsuchikama, Kyoji
    MOLECULAR CANCER THERAPEUTICS, 2022, 21 (09) : 1449 - 1461
  • [49] Effect of Linker Stereochemistry on the Activity of Indolinobenzodiazepine Containing Antibody-Drug Conjugates (ADCs)
    Reid, Emily E.
    Archer, Katie E.
    Shizuka, Manami
    Wilhelm, Alan
    Yoder, Nicholas C.
    Bai, Chen
    Fishkin, Nathan E.
    Harris, Luke
    Maloney, Erin K.
    Salomon, Paulin
    Hong, Erica
    Wu, Rui
    Ab, Olga
    Jin, Shan
    Lai, Katharine C.
    Sikka, Surina
    Chari, Ravi V. J.
    Miller, Michael L.
    ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (08): : 1193 - 1197
  • [50] Linker and Conjugation Site Synergy in Antibody-Drug Conjugates: Impacts on Biological Activity
    Aoyama, Michihiko
    Tada, Minoru
    Yokoo, Hidetomo
    Ito, Takahito
    Misawa, Takashi
    Demizu, Yosuke
    Ishii-Watabe, Akiko
    BIOCONJUGATE CHEMISTRY, 2024, 35 (10) : 1568 - 1576